Retreatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin
Publication Type:
Journal Article
Authors:
Stefan Zeuzem;
Ira M. Jacobson;
Baykal, T.;
Marinho, R.T.;
Fred Poordad;
Bourliere, M.;
M S Sulkowski;
Wedemeyer, H.;
Tam, E.;
Desmond, P.;
Jensen, D.M.;
A M Di Bisceglie;
Varunok, P.;
Hassanein, T.;
Xiong, J.;
Pilot-Matias, T.;
DaSilva-Tillmann, B.;
Larsen, L.;
Podsadecki, T.;
Bernstein, B.Source:
N Engl J Med, Volume 370, Issue 17, p.1604-1614 (2014)
Keywords:
analysis,
Australia,
Baltimore,
California,
Canada,
Chicago,
Disease,
France,
Genotype,
genotype 1,
Germany,
HCV,
Health,
Illinois,
Infection,
Liver,
Liver Diseases,
methods,
New York,
Patients,
Placebos,
Pruritus,
Research,
Research Support,
Retreatment,
Ribavirin,
ritonavir,
Safety,
sustained virologic response,
Telaprevir,
Texas,
treatment
